38869264|t|The impact of melatonin on postoperative delirium in geriatric patients after colorectal surgery: a randomized placebo-controlled trial.
38869264|a|BACKGROUND: The current study was designed to evaluate the role of prophylactic melatonin administration in reducing delirium occurrence in elderly patients undergoing colorectal cancer surgeries. METHODS: One hundred patients of both genders undergoing elective colorectal cancer surgeries under general anesthesia were randomly allocated into two equal groups. A treatment group of patients (Melatonin group) received five mg of melatonin the night before surgery, twelve hours before the scheduled surgery time, and an additional five mg of melatonin two hours before surgery. The control group of patients received placebo tablets at the same time points. Delirium score, sedation score, pain score, hemodynamics, oxygen saturation, and blood requirements were recorded. RESULTS: Twenty-eight patients (56%) in the control group versus 18 (36%) in the melatonin group developed delirium (P=0.045), OR=2.26, 95% CI: 1.013-5.05. Five patients (18%) in the control group versus six (33%) in the melatonin group developed delirium on discharge from the recovery room (P=0.749), OR=1.22, 95% CI: 0.34-4.31, while 23 patients (82%) in the control group versus 12 (66%) in the melatonin group developed delirium six hours postoperative (P=0.021), OR=1.705, 95% CI: 1.02-2.81 with higher nursing delirium screening score in the control group 2 (1, 4) versus 1 (0, 2) in the melatonin group (P=0.002), 95% CI: 1.77-2.71. CONCLUSIONS: The prophylactic administration of melatonin may decrease the incidence of postoperative delirium in elderly patients undergoing colorectal surgeries under general anesthesia.
38869264	14	23	melatonin	Chemical	MESH:D008550
38869264	27	49	postoperative delirium	Disease	MESH:D000071257
38869264	63	71	patients	Species	9606
38869264	78	88	colorectal	Disease	MESH:D015179
38869264	217	226	melatonin	Chemical	MESH:D008550
38869264	254	262	delirium	Disease	MESH:D003693
38869264	285	293	patients	Species	9606
38869264	305	322	colorectal cancer	Disease	MESH:D015179
38869264	355	363	patients	Species	9606
38869264	400	417	colorectal cancer	Disease	MESH:D015179
38869264	521	529	patients	Species	9606
38869264	531	540	Melatonin	Chemical	MESH:D008550
38869264	568	577	melatonin	Chemical	MESH:D008550
38869264	681	690	melatonin	Chemical	MESH:D008550
38869264	738	746	patients	Species	9606
38869264	797	805	Delirium	Disease	MESH:D003693
38869264	829	833	pain	Disease	MESH:D010146
38869264	855	861	oxygen	Chemical	MESH:D010100
38869264	934	942	patients	Species	9606
38869264	993	1002	melatonin	Chemical	MESH:D008550
38869264	1019	1027	delirium	Disease	MESH:D003693
38869264	1073	1081	patients	Species	9606
38869264	1133	1142	melatonin	Chemical	MESH:D008550
38869264	1159	1167	delirium	Disease	MESH:D003693
38869264	1252	1260	patients	Species	9606
38869264	1311	1320	melatonin	Chemical	MESH:D008550
38869264	1337	1345	delirium	Disease	MESH:D003693
38869264	1429	1437	delirium	Disease	MESH:D003693
38869264	1507	1516	melatonin	Chemical	MESH:D008550
38869264	1601	1610	melatonin	Chemical	MESH:D008550
38869264	1641	1663	postoperative delirium	Disease	MESH:D000071257
38869264	1675	1683	patients	Species	9606
38869264	1695	1705	colorectal	Disease	MESH:D015179
38869264	Negative_Correlation	MESH:D008550	MESH:D003693
38869264	Negative_Correlation	MESH:D008550	MESH:D000071257
38869264	Negative_Correlation	MESH:D008550	MESH:D015179

